烟酰胺单核苷酸在代谢性疾病治疗中的研究进展
Advances in the Study of Nicotinamide Mononucleotides in the Treatment of Metabolic Diseases
DOI: 10.12677/acm.2025.1561781, PDF,   
作者: 时漪涵：山东大学齐鲁医学院(第一临床学院)，山东 济南
关键词: 烟酰胺单核苷酸；代谢性疾病；NAD+前体；衰老；Nicotinamide Mononucleotide； Metabolic Disease； NAD+ Precursor； Aging
摘要: 烟酰胺单核苷酸(NMN)作为烟酰胺腺嘌呤二核苷酸(NAD+)的前体分子，近年来在代谢性疾病治疗和衰老干预方面引起了广泛关注。NAD+在细胞内发挥着多种重要的生物学功能，包括能量代谢、DNA修复、免疫调节及抗衰老等。随着年龄增长，NAD+水平逐渐下降，这与多种代谢性疾病如糖尿病、肥胖症、非酒精性脂肪性肝病及衰老过程密切相关。NMN通过提升NAD+水平，已经在动物实验和初步临床研究中表现出显著的治疗潜力，尤其在改善代谢紊乱、减缓衰老及相关并发症方面展现了积极的效果。研究表明，NMN能够调节多个关键的代谢途径，如胰岛素信号通路、线粒体功能及抗氧化反应等，从而改善代谢性疾病的病理变化。本文综述了NMN在代谢性疾病中的作用及机制，探讨了其临床应用前景，并提出了当前研究中的不足与挑战。未来的研究应聚焦于临床验证、NMN的生物利用度、作用机制的深入探索，以及与其他治疗策略的协同效应，为NMN的临床应用提供更加坚实的科学依据。
Abstract: Nicotinamide mononucleotide (NMN), as a precursor molecule of nicotinamide adenine dinucleotide (NAD+), has attracted much attention in recent years in the treatment of metabolic diseases and aging interventions. NAD+ performs a variety of important biological functions in cells, including energy metabolism, DNA repair, immune regulation, and anti-aging. NAD+ levels decline with age, which is closely related to a variety of metabolic diseases such as diabetes, obesity, non-alcoholic fatty liver disease, and the aging process. NMN has demonstrated significant therapeutic potential in animal experiments and preliminary clinical studies by elevating NAD+ levels, and has shown positive effects in improving metabolic disorders, slowing down the aging process, and related complications. Studies have shown that NMN can modulate several key metabolic pathways, such as insulin signaling pathway, mitochondrial function and antioxidant response, and thus ameliorate pathological changes in metabolic diseases. This article summarizes the role and mechanism of NMN in metabolic diseases, discusses the prospect of its clinical application, and presents the shortcomings and challenges in current research. Future studies should focus on clinical validation, bioavailability of NMN, in-depth exploration of the mechanism of action, and synergistic effects with other therapeutic strategies to provide a more solid scientific basis for the clinical application of NMN.
文章引用：时漪涵. 烟酰胺单核苷酸在代谢性疾病治疗中的研究进展[J]. 临床医学进展, 2025, 15(6): 721-727. https://doi.org/10.12677/acm.2025.1561781

参考文献

[1] Mills, K.F., Yoshida, S., Stein, L.R., Grozio, A., Kubota, S., Sasaki, Y., et al. (2016) Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice. Cell Metabolism, 24, 795-806. [Google Scholar] [CrossRef] [PubMed]
[2] Yamaguchi, S., Franczyk, M.P., Chondronikola, M., Qi, N., Gunawardana, S.C., Stromsdorfer, K.L., et al. (2019) Adipose Tissue NAD+ Biosynthesis Is Required for Regulating Adaptive Thermogenesis and Whole-Body Energy Homeostasis in Mice. Proceedings of the National Academy of Sciences, 116, 23822-23828. [Google Scholar] [CrossRef] [PubMed]
[3] Abdellatif, M., Sedej, S. and Kroemer, G. (2021) NAD+ Metabolism in Cardiac Health, Aging, and Disease. Circulation, 144, 1795-1817. [Google Scholar] [CrossRef] [PubMed]
[4] Lautrup, S., Sinclair, D.A., Mattson, M.P. and Fang, E.F. (2019) NAD+ in Brain Aging and Neurodegenerative Disorders. Cell Metabolism, 30, 630-655. [Google Scholar] [CrossRef] [PubMed]
[5] Huang, Q., Sun, M., Li, M., Zhang, D., Han, F., Wu, J.C., et al. (2018) Combination of NAD+ and NADPH Offers Greater Neuroprotection in Ischemic Stroke Models by Relieving Metabolic Stress. Molecular Neurobiology, 55, 6063-6075. [Google Scholar] [CrossRef] [PubMed]
[6] Saville, K.M., Clark, J., Wilk, A., Rogers, G.D., Andrews, J.F., Koczor, C.A., et al. (2020) NAD+-Mediated Regulation of Mammalian Base Excision Repair. DNA Repair, 93, Article 102930. [Google Scholar] [CrossRef] [PubMed]
[7] Berger, F. (2004) The New Life of a Centenarian: Signalling Functions of NAD(P). Trends in Biochemical Sciences, 29, 111-118. [Google Scholar] [CrossRef] [PubMed]
[8] Xie, N., Zhang, L., Gao, W., Huang, C., Huber, P.E., Zhou, X., et al. (2020) NAD+ Metabolism: Pathophysiologic Mechanisms and Therapeutic Potential. Signal Transduction and Targeted Therapy, 5, Article No. 227. [Google Scholar] [CrossRef] [PubMed]
[9] Ummarino, S., Hausman, C., Gaggi, G., Rinaldi, L., Bassal, M.A., Zhang, Y., et al. (2021) NAD Modulates DNA Methylation and Cell Differentiation. Cells, 10, Article 2986. [Google Scholar] [CrossRef] [PubMed]
[10] Zhang, H., Ryu, D., Wu, Y., Gariani, K., Wang, X., Luan, P., et al. (2016) NAD+ Repletion Improves Mitochondrial and Stem Cell Function and Enhances Life Span in Mice. Science, 352, 1436-1443. [Google Scholar] [CrossRef] [PubMed]
[11] Massudi, H., Grant, R., Braidy, N., Guest, J., Farnsworth, B. and Guillemin, G.J. (2012) Age-Associated Changes in Oxidative Stress and NAD+ Metabolism in Human Tissue. PLOS ONE, 7, e42357. [Google Scholar] [CrossRef] [PubMed]
[12] Seyedsadjadi, N., Berg, J., Bilgin, A.A., Braidy, N., Salonikas, C. and Grant, R. (2018) High Protein Intake Is Associated with Low Plasma NAD+ Levels in a Healthy Human Cohort. PLOS ONE, 13, e0201968. [Google Scholar] [CrossRef] [PubMed]
[13] Yoshino, J., Mills, K.F., Yoon, M.J. and Imai, S. (2011) Nicotinamide Mononucleotide, a Key NAD+ Intermediate, Treats the Pathophysiology of Diet-and Age-Induced Diabetes in Mice. Cell Metabolism, 14, 528-536. [Google Scholar] [CrossRef] [PubMed]
[14] Johnson, S. and Imai, S. (2018) NAD+ Biosynthesis, Aging, and Disease. F1000Research, 7, Article 132. [Google Scholar] [CrossRef] [PubMed]
[15] Imai, S. and Guarente, L. (2014) NAD+ and Sirtuins in Aging and Disease. Trends in Cell Biology, 24, 464-471. [Google Scholar] [CrossRef] [PubMed]
[16] Heer, C.D., Sanderson, D.J., Voth, L.S., Alhammad, Y.M.O., Schmidt, M.S., Trammell, S.A.J., et al. (2020) Coronavirus Infection and PARP Expression Dysregulate the NAD Metabolome: An Actionable Component of Innate Immunity. Journal of Biological Chemistry, 295, 17986-17996. [Google Scholar] [CrossRef] [PubMed]
[17] Huizenga, R. (2020) Dramatic Clinical Improvement in Nine Consecutive Acutely Ill Elderly COVID-19 Patients Treated with a Nicotinamide Mononucleotide Cocktail: A Case Series. SSRN Electronic Journal.
[18] Trammell, S.A.J., Weidemann, B.J., Chadda, A., Yorek, M.S., Holmes, A., Coppey, L.J., et al. (2016) Nicotinamide Riboside Opposes Type 2 Diabetes and Neuropathy in Mice. Scientific Reports, 6, Article No. 26933. [Google Scholar] [CrossRef] [PubMed]
[19] Hu, L., Guo, Y., Song, L., Wen, H., Sun, N., Wang, Y., et al. (2022) Nicotinamide Riboside Promotes Mfn2-Mediated Mitochondrial Fusion in Diabetic Hearts through the SIRT1-PGC1α-PPARα Pathway. Free Radical Biology and Medicine, 183, 75-88. [Google Scholar] [CrossRef] [PubMed]
[20] Caton, P.W., Kieswich, J., Yaqoob, M.M., Holness, M.J. and Sugden, M.C. (2011) Nicotinamide Mononucleotide Protects against Pro-Inflammatory Cytokine-Mediated Impairment of Mouse Islet Function. Diabetologia, 54, 3083-3092.
[21] Gariani, K., Menzies, K.J., Ryu, D., Wegner, C.J., Wang, X., Ropelle, E.R., et al. (2016) Eliciting the Mitochondrial Unfolded Protein Response by Nicotinamide Adenine Dinucleotide Repletion Reverses Fatty Liver Disease in Mice. Hepatology, 63, 1190-1204.
[22] Wang, X., Hu, X., Yang, Y., Takata, T. and Sakurai, T. (2016) Nicotinamide Mononucleotide Protects against β-Amyloid Oligomer-Induced Cognitive Impairment and Neuronal Death. Brain Research, 1643, 1-9. [Google Scholar] [CrossRef] [PubMed]
[23] Yao, Z., Yang, W., Gao, Z. and Jia, P. (2017) Nicotinamide Mononucleotide Inhibits JNK Activation to Reverse Alzheimer Disease. Neuroscience Letters, 647, 133-140. [Google Scholar] [CrossRef] [PubMed]
[24] Hou, Y., Lautrup, S., Cordonnier, S., Wang, Y., Croteau, D.L., Zavala, E., et al. (2018) NAD+ Supplementation Normalizes key Alzheimer’s Features and DNA Damage Responses in a New AD Mouse Model with Introduced DNA Repair Deficiency. Proceedings of the National Academy of Sciences of the United States of America, 115, E1876-E1885.
[25] Ito, S., Gotow, T., Suetake, I. and Nagai, K. (2020) Protective Effects of Nicotinamide Mononucleotide against Oxidative Stress-Induced PC12 Cell Death via Mitochondrial Enhancement. PharmaNutrition, 11, Article 100175. [Google Scholar] [CrossRef] 
[26] Chandrasekaran, K., Choi, J., Arvas, M.I., Salimian, M., Singh, S., Xu, S., et al. (2020) Nicotinamide Mononucleotide Administration Prevents Experimental Diabetes-Induced Cognitive Impairment and Loss of Hippocampal Neurons. International Journal of Molecular Sciences, 21, Article 3756. [Google Scholar] [CrossRef] [PubMed]
[27] Gong, B., Pan, Y., Vempati, P., Zhao, W., Knable, L., Ho, L., et al. (2013) Nicotinamide Riboside Restores Cognition through an Upregulation of Proliferator-Activated Receptor-γ Coactivator 1α Regulated β-Secretase 1 Degradation and Mitochondrial Gene Expression in Alzheimer’s Mouse Models. Neurobiology of Aging, 34, 1581-1588. [Google Scholar] [CrossRef] [PubMed]
[28] Guan, Y., Wang, S.-R., Huang, X.-Z., Xie, Q, Xu, Y.-Y., Shang, D., et al. (2017) Nicotinamide Mononucleotide, an NAD+ Precursor, Rescues Age-Associated Susceptibility to AKI in a Sirtuin 1-Dependent Manner. Journal of the American Society of Nephrology, 28, 2337-2352.
[29] Elhassan, Y.S., Kluckova, K., Fletcher, R.S., Schmidt, M.S., Garten, A., Doig, C.L., et al. (2019) Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome and Induces Transcriptomic and Anti-Inflammatory Signatures. Cell Reports, 28, 1717-1728.e6. [Google Scholar] [CrossRef] [PubMed]
[30] Traba, J., Kwarteng-Siaw, M., Okoli, T.C., Li, J., Huffstutler, R.D., Bray, A., et al. (2015) Fasting and Refeeding Differentially Regulate NLRP3 Inflammasome Activation in Human Subjects. Journal of Clinical Investigation, 125, 4592-4600. [Google Scholar] [CrossRef] [PubMed]
[31] Liu, J., Zong, Z., Zhang, W., Chen, Y., Wang, X., Shen, J., et al. (2021) Nicotinamide Mononucleotide Alleviates LPS-Induced Inflammation and Oxidative Stress via Decreasing COX-2 Expression in Macrophages. Frontiers in Molecular Biosciences, 8, Article 702107. [Google Scholar] [CrossRef] [PubMed]
[32] de Picciotto, N.E., Gano, L.B., Johnson, L.C., Martens, C.R., Sindler, A.L., Mills, K.F., et al. (2016) Nicotinamide Mononucleotide Supplementation Reverses Vascular Dysfunction and Oxidative Stress with Aging in Mice. Aging Cell, 15, 522-530.
[33] Yamamoto, T., Byun, J., Zhai, P., Ikeda, Y., Oka, S. and Sadoshima, J. (2014) Nicotinamide Mononucleotide, an Intermediate of NAD+ Synthesis, Protects the Heart from Ischemia and Reperfusion. PLOS ONE, 9, e98972. [Google Scholar] [CrossRef] [PubMed]
[34] Martens, C.R., Denman, B.A., Mazzo, M.R., Armstrong, M.L., Reisdorph, N., McQueen, M.B., et al. (2018) Chronic Nicotinamide Riboside Supplementation Is Well-Tolerated and Elevates NAD+ in Healthy Middle-Aged and Older Adults. Nature Communications, 9, Article No. 1286.
[35] Diguet, N., Trammell, S.A.J., Tannous, C., Deloux, R., Piquereau, J., Mougenot, N., et al. (2018) Nicotinamide Riboside Preserves Cardiac Function in a Mouse Model of Dilated Cardiomyopathy. Circulation, 137, 2256-2273.
[36] Amano, H., Chaudhury, A., Rodriguez-Aguayo, C., Lu, L., Akhanov, V., Catic, A., et al. (2019) Telomere Dysfunction Induces Sirtuin Repression that Drives Telomere-Dependent Disease. Cell Metabolism, 29, 1274-1290.
[37] Niu, K., Bao, T., Gao, L., Ru, M., Li, Y., Jiang, L., et al. (2021) The Impacts of Short-Term NMN Supplementation on Serum Metabolism, Fecal Microbiota, and Telomere Length in Pre-Aging Phase. Frontiers in Nutrition, 8, Article 756243. [Google Scholar] [CrossRef] [PubMed]
[38] Yoshino, M., Yoshino, J., Kayser, B.D., Patti, G.J., Franczyk, M.P., Mills, K.F., et al. (2021) Nicotinamide Mononucleotide Increases Muscle Insulin Sensitivity in Prediabetic Women. Science, 372, 1224-1229. [Google Scholar] [CrossRef] [PubMed]
[39] Conze, D., Brenner, C. and Kruger, C.L. (2019) Safety and Metabolism of Long-Term Administration of NIAGEN (Nicotinamide Riboside Chloride) in a Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Healthy Overweight Adults. Scientific Reports, 9, Article No. 9772.
[40] Irie, J., Inagaki, E., Fujita, M., Nakaya, H., Mitsuishi, M., Yamaguchi, S., et al. (2020) Effect of Oral Administration of Nicotinamide Mononucleotide on Clinical Parameters and Nicotinamide Metabolite Levels in Healthy Japanese Men. Endocrine Journal, 67, 153-160. [Google Scholar] [CrossRef] [PubMed]
[41] Trammell, S.A., Yu, L., Redpath, P., Migaud, M.E. and Brenner, C. (2016) Nicotinamide Riboside Is a Major NAD+ Precursor Vitamin in Cow Milk. The Journal of Nutrition, 146, 957-963. [Google Scholar] [CrossRef] [PubMed]
[42] Ummarino, S., Mozzon, M., Zamporlini, F., Amici, A., Mazzola, F., Orsomando, G., et al. (2017) Simultaneous Quantitation of Nicotinamide Riboside, Nicotinamide Mononucleotide and Nicotinamide Adenine Dinucleotide in Milk by a Novel Enzyme-Coupled Assay. Food Chemistry, 221, 161-168. [Google Scholar] [CrossRef] [PubMed]
[43] Kim, L.-J., Chalmers, T.J., Smith, G.C., Das, A., Poon, E.W.K., Wang, J., et al. (2022) Mononucleotide (NMN) Deamidation by Host-Microbiome Interactions. bioRxiv.
[44] Yi, L., Maier, A.B., Tao, R., Lin, Z., Vaidya, A., Pendse, S., et al. (2023) The Efficacy and Safety of β-Nicotinamide Mononucleotide (NMN) Supplementation in Healthy Middle-Aged Adults: A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Dependent Clinical Trial. GeroScience, 45, 29-43. [Google Scholar] [CrossRef] [PubMed]
[45] Shats, I., Williams, J.G., Liu, J., Makarov, M.V., Wu, X., Lih, F.B., et al. (2020) Bacteria Boost Mammalian Host NAD Metabolism by Engaging the Deamidated Biosynthesis Pathway. Cell Metabolism, 31, 564-579.E7. [Google Scholar] [CrossRef] [PubMed]
[46] Huang, P., Jiang, A., Wang, X., Zhou, Y., Tang, W., Ren, C., et al. (2021) NMN Maintains Intestinal Homeostasis by Regulating the Gut Microbiota. Frontiers in Nutrition, 8, Article 714604. [Google Scholar] [CrossRef] [PubMed]
[47] Huang, P., Wang, X., Wang, S., Wu, Z., Zhou, Z., Shao, G., et al. (2022) Treatment of Inflammatory Bowel Disease: Potential Effect of NMN on Intestinal Barrier and Gut Microbiota. Current Research in Food Science, 5, 1403-1411. [Google Scholar] [CrossRef] [PubMed]
[48] Turroni, F., Ventura, M., Buttó, L.F., Duranti, S., O’Toole, P.W., Motherway, M.O., et al. (2014) Molecular Dialogue between the Human Gut Microbiota and the Host: A Lactobacillus and Bifidobacterium perspective. Cellular and Molecular Life Sciences, 71, 183-203. [Google Scholar] [CrossRef] [PubMed]
[49] Wellman, A.S., Metukuri, M.R., Kazgan, N., Xu, X., Xu, Q., Ren, N.S.X., et al. (2017) Intestinal Epithelial Sirtuin 1 Regulates Intestinal Inflammation during Aging in Mice by Altering the Intestinal Microbiota. Gastroenterology, 153, 772-786. [Google Scholar] [CrossRef] [PubMed]

为你推荐